Human TruStain FcXTM and 1 more item

The University of Virginia awarded purchase order A207_PO-0457066 to BioLegend Inc. on July 10, 2026, for laboratory reagents and immunological research materials. The contract encompasses two primary line items: Human TruStain FcX, a Fc receptor blocking reagent, and Brilliant Violet 605 Streptavidin, a fluorescent labeling conjugate. Both items were procured in quantities of two units each, with delivery directed to Selin Ustel. The cumulative contract value totals $667.00, reflecting unit prices of $160.30 and $173.25 respectively.

As a Virginia-based procurement executed by the University of Virginia, the contract represents a routine supply acquisition for research or laboratory operations. BioLegend Inc. served as the prime contractor for this purchase order. The specific delivery location for these materials was designated to the named recipient at the University of Virginia, consistent with institutional research or clinical laboratory requirements. The modest contract value and single-purchase structure suggest this represents a point-in-time procurement rather than an ongoing supply agreement.